LCT | Lactase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| ![](/images/7408/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7408/21159_B_9_2_rna_selected_60x60.jpg) | Group enriched |
CCL25 | Chemokine (C-C motif) ligand 25 | Predicted secreted proteins
| ![](/images/55883/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55883/125527_B_4_5_rna_selected_60x60.jpg) | Group enriched |
DEFA5 | Defensin, alpha 5, Paneth cell-specific | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15775/141535_B_8_1_rna_selected_60x60.jpg) | Group enriched |
DEFA6 | Defensin, alpha 6, Paneth cell-specific | Plasma proteins Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19462/140672_B_9_3_rna_selected_60x60.jpg) | Group enriched |
MS4A10 | Membrane-spanning 4-domains, subfamily A, member 10 | Predicted membrane proteins Transporters
| ![](/images/14778/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14778/34286_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33671/76711_B_9_7_rna_selected_60x60.jpg) | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/49793/141695_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CPO | Carboxypeptidase O | Enzymes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
C17orf78 | Chromosome 17 open reading frame 78 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13699/29955_B_9_1_rna_selected_60x60.jpg) | Group enriched |
GIP | Gastric inhibitory polypeptide | Plasma proteins Predicted secreted proteins
| | ![](/images/21612/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21612/140668_B_8_3_rna_selected_60x60.jpg) | Group enriched |
RBP2 | Retinol binding protein 2, cellular | Transporters
| | ![](/images/35866/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/35866/74165_B_9_6_rna_selected_60x60.jpg) | Group enriched |
CREB3L3 | CAMP responsive element binding protein 3-like 3 | Predicted membrane proteins Transcription factors
| ![](/images/40671/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40671/86502_B_8_2_rna_selected_60x60.jpg) | Group enriched |
UGT1A5 | UDP glucuronosyltransferase 1 family, polypeptide A5 | Enzymes Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CYP1A1 | Cytochrome P450, family 1, subfamily A, polypeptide 1 | Enzymes Plasma proteins Predicted membrane proteins
| ![](/images/18654/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18654/41747_B_9_1_rna_selected_60x60.jpg) | Group enriched |
UGT1A1 | UDP glucuronosyltransferase 1 family, polypeptide A1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
SLC34A3 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/23776/51459_B_9_2_rna_selected_60x60.jpg) | Group enriched |
ISX | Intestine-specific homeobox | Transcription factors
| ![](/images/60328/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60328/138009_B_8_2_rna_selected_60x60.jpg) | Group enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | ![](/images/2549/ihc_cell_selected_60x60.jpg) | ![](/images/1352/3295_B_9_3_rna_selected_60x60.jpg) | Group enriched |
TM4SF20 | Transmembrane 4 L six family member 20 | Disease related genes Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25163/57017_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | ![](/images/21400/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3781/10124_B_8_6_rna_selected_60x60.jpg) | Group enriched |
SLC10A2 | Solute carrier family 10 (sodium/bile acid cotransporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/4795/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4795/13413_B_9_2_rna_selected_60x60.jpg) | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/19551/ihc_cell_selected_60x60.jpg) | ![](/images/19551/127893_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CUBN | Cubilin (intrinsic factor-cobalamin receptor) | Disease related genes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/16514/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16514/37552_B_8_1_rna_selected_60x60.jpg) | Group enriched |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/19556/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19556/45601_B_8_1_rna_selected_60x60.jpg) | Group enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images/7040/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/7040/19610_B_9_1_rna_selected_60x60.jpg) | Group enriched |
FABP6 | Fatty acid binding protein 6, ileal | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12601/58468_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
MEP1B | Meprin A, beta | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29119/137887_B_1_5_rna_selected_60x60.jpg) | Group enriched |
TMIGD1 | Transmembrane and immunoglobulin domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| ![](/images/21946/ihc_selected_60x60.jpg) | ![](/images/21946/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21946/50852_B_9_8_rna_selected_60x60.jpg) | Group enriched |
C19orf69 | Chromosome 19 open reading frame 69 | | ![](/images/42632/ihc_selected_60x60.jpg) | ![](/images/48484/if_selected_60x60.jpg) | ![](/images/48484/ihc_cell_selected_60x60.jpg) | ![](/images/42632/93464_B_9_1_rna_selected_60x60.jpg) | Group enriched |
REG3A | Regenerating islet-derived 3 alpha | Plasma proteins Predicted secreted proteins Transporters
| ![](/images/48334/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48334/126922_B_9_1_rna_selected_60x60.jpg) | Group enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4860/14118_B_8_6_rna_selected_60x60.jpg) | Group enriched |
BTNL3 | Butyrophilin-like 3 | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CEACAM18 | Carcinoembryonic antigen-related cell adhesion molecule 18 | Predicted membrane proteins Predicted secreted proteins
| ![](/images/59487/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/59487/132848_B_9_2_rna_selected_60x60.jpg) | Group enriched |
CHP2 | Calcineurin-like EF-hand protein 2 | Cancer-related genes
| ![](/images/72806/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/72806/153331_B_8_2_rna_selected_60x60.jpg) | Group enriched |
SLC52A1 | Solute carrier family 52 (riboflavin transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/11449/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11449/27035_B_8_5_rna_selected_60x60.jpg) | Group enriched |
ALPI | Alkaline phosphatase, intestinal | Enzymes Predicted secreted proteins
| ![](/images/51699/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51699/138819_B_8_3_rna_selected_60x60.jpg) | Group enriched |
GUCA2B | Guanylate cyclase activator 2B (uroguanylin) | Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | ![](/images/243/ihc_cell_selected_60x60.jpg) | ![](/images/243/579_A_2_4_rna_selected_60x60.jpg) | Group enriched |
MALRD1 | MAM and LDL receptor class A domain containing 1 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46848/106956_B_7_8_rna_selected_60x60.jpg) | Group enriched |
SLC6A19 | Solute carrier family 6 (neutral amino acid transporter), member 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/37415/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37415/79704_B_9_5_rna_selected_60x60.jpg) | Group enriched |
ASAH2C | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C | Enzymes
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
MTTP | Microsomal triglyceride transfer protein | Disease related genes FDA approved drug targets Predicted secreted proteins
| ![](/images/54862/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54862/128137_B_8_2_rna_selected_60x60.jpg) | Group enriched |
SLC39A5 | Solute carrier family 39 (zinc transporter), member 5 | Predicted membrane proteins Predicted secreted proteins Transporters
| ![](/images/18423/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18423/43605_B_9_2_rna_selected_60x60.jpg) | Group enriched |
TBX10 | T-box 10 | Predicted secreted proteins Transcription factors
| ![](/images/47881/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47881/109018_B_8_3_rna_selected_60x60.jpg) | Group enriched |
SLC5A12 | Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 | Predicted membrane proteins Transporters
| ![](/images/45181/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45181/103045_B_9_2_rna_selected_60x60.jpg) | Group enriched |
XPNPEP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/339/623_B_9_3_rna_selected_60x60.jpg) | Group enriched |
GUCY2C | Guanylate cyclase 2C (heat stable enterotoxin receptor) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| ![](/images/37655/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37655/78313_B_8_5_rna_selected_60x60.jpg) | Group enriched |
MOGAT2 | Monoacylglycerol O-acyltransferase 2 | Enzymes Predicted membrane proteins
| ![](/images/28834/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28834/60966_B_9_2_rna_selected_60x60.jpg) | Group enriched |